Long‐Term Health Outcomes of Individuals With Pseudodeficiency Alleles in <scp> <i>IDUA</i> </scp> May Inform Newborn Screening Practices for Mucopolysaccharidosis Type I
Lauren O’Grady(Massachusetts General Hospital), Nina B. Gold(Harvard University), Amel Karaa(Istituto delle Scienze Neurologiche di Bologna), Alanna Strong(Children's Hospital of Philadelphia), Inderneel Sahai(Massachusetts General Hospital), Hana Zouk(Harvard University), L. Clarke(University of British Columbia), Jessica A. Gold(Washington University in St. Louis), Emilie S. Zoltick(Boston University), Julie Yeo(Massachusetts General Hospital), Wei He(Massachusetts General Hospital), Robert C. Green(Boston University), Emma Perez(Brigham and Women's Hospital)
Cited by 3
Related Papers
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
|Nature Communications|2020|539
Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing
|Circulation Research|2014|527
Predicting Alzheimer’s disease progression using multi-modal deep learning approach
|Scientific Reports|2019|401